Search

everythinglearnresearchcommunity

for

Search:↓

Phosphatidylinositol 4-kinases are crucial for root growth, defense, and immunity in Arabidopsis thaliana.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

JAK inhibitors effectively treat inflammatory skin diseases by targeting specific cytokine signals.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Blocking interferon-gamma might help treat various autoimmune diseases.

Trichosanthes kirilowii extract helps wounds heal faster.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

Tofacitinib is a promising treatment for children with rheumatic diseases.

c-Kit is important for heart regeneration and cancer development.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Vesicles made of behenyltrimethylammonium chloride and stearic acid can triple the skin absorption of hinokitiol, which may help with hair growth.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.